Sanofi, 10% Owner at ALNYLAM PHARMACEUTICALS, INC. (ALNY), bought 595,002 shares at $71.87 ($42.8M) on 2017-05-31, disclosed to the SEC on 2017-06-01.
Open-market purchase of $42.8M ALNY by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.87 | 297,501 | $21.4M | 50.0% |
| 2 | $71.87 | 297,501 | $21.4M | 50.0% |
| Total | $71.87 avg | 595,002 | $42.8M | 100% |
| Filing → |
| ICVX | BUY | 2021-08-02 | $1.0M | — | Filing → |
| INZY | BUY | 2020-07-29 | $1.3M | — | Filing → |
| REGN | SELL | 2020-06-11 | $143.7M | — | Filing → |